A randomized, open-label study comparing the anti-tumor effect of treatment with Tarceva plus Avastin versus chemotherapy plus Avastin in patients with advanced non-small cell lung cancer

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 05 Oct 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Bevacizumab (Primary) ; Erlotinib (Primary) ; Antineoplastics; Carboplatin; Cisplatin; Gemcitabine; Paclitaxel
Indications Non-small cell lung cancer
Focus Therapeutic Use
Sponsors Roche

29 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
14 Oct 2011 Planned end date changed from 1 Sep 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.
15 Jul 2011 Planned end date changed from 1 May 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com